Joel Greenblatt's RVMD Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 99,114 shares of Revolution Medicines, Inc. (RVMD) worth $4.63 M, representing 0.02% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in RVMD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +99,114 | New Buy | 99,114 | $46.70 |
Joel Greenblatt's Revolution Medicines Investment FAQs
Joel Greenblatt first purchased Revolution Medicines, Inc. (RVMD) in Q3 2025, acquiring 99,114 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Revolution Medicines, Inc. (RVMD) for 1 quarters since Q3 2025.
Joel Greenblatt's largest addition to Revolution Medicines, Inc. (RVMD) was in Q3 2025, adding 99,114 shares worth $4.63 M.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 99,114 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $4.63 M.
As of the Q3 2025 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.02% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Revolution Medicines, Inc. (RVMD) was 99,114 shares, as reported at the end of Q3 2025.